Zusammenfassung
Akne ist weltweit die häufigste dermatologische Erkrankung. Um eine angesichts variierender klinischer Bilder geeignete Therapie ansetzen zu können, sind gute Kenntnisse über die Pathophysiologie der Erkrankung nötig. In den letzten 15 Jahren wurden neue Konzepte zur Pathophysiologie der Akne entwickelt. Acne vulgaris ist eine entzündliche Erkrankung, bei deren Entstehung Androgene, PPAR (Peroxisom-Proliferation-aktivierende Rezeptoren)-Liganden, regulierende Neuropeptide und Umweltfaktoren beteiligt sein können. Diese Faktoren unterbrechen den natürlichen zyklischen Prozess im Talgdrüsenfollikel und unterstützen den Übergang von Mikrokomedonen zu Komedonen und den klinisch entzündlichen Effloreszenzen. Proinflammatorische Lipide, Chemokine und Zytokine übernehmen die Vermittlerrolle bei der Entwicklung von Akneeffloreszenzen. Bakterielle Antigene können die entzündlichen Phänomene verstärken.
Abstract
Acne is the most common skin disease worldwide. Choosing the appropriate therapeutic regimens for the clinically diversified disease phenotypes require good knowledge of its pathophysiology. New concepts in this field have been developed in the last 15 years. Acne vulgaris is an inflammatory disorder in which androgens, PPAR ligands, regulating neuropeptides and environmental factors are probably involved as triggers. These factors interrupt the natural cycling process in the sebaceous gland follicle and support the transition of microcomedones to comedones and clinically inflammatory lesions. Proinflammatory lipids, chemokines and cytokines overtake the role of mediators for the further development of acne lesions. Bacterial antigens can potentate the inflammatory phenomena.
Literatur
Adebamowo CA, Spiegelman D, Berkey CS et al (2008) Milk consumption and acne in teenaged boys. J Am Acad Dermatol 58:787–793
Alestas T, Ganceviciene R, Fimmel S et al (2006) Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 84:75–87
Alexeyev O, Lundskog B, Ganceviciene R et al (2012) Pattern of tissue invasion by Propionibacterium acnes in acne vulgaris. J Dermatol Sci 67:63–66
Capitanio B, Sinagra JL, Bordignon V et al (2010) Underestimated clinical features of post adolescent acne. J Am Acad Dermatol 63:782–788
Chen W, Tsai S-J, Sheu H-M et al (2010) Testosterone synthesized in cultured human SZ95 sebocytes mainly derives from dehydroepiandrosterone. Exp Dermatol 19:470–472
Cordain L, Lindeberg S, Hurtado M et al (2002) Acne vulgaris: a disease of Western civilization. Arch Dermatol 138:1584–1590
Cunliffe WJ, Holland DB, Clark SM, Stables GI (2000) Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 142:1084–1091
Ghodsi SZ, Orawa H, Zouboulis CC (2009) Prevalence, severity and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 129:2136–2141
Green J, Sinclair RD (2001) Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 42:98–101
Guy R, Green M, Kealey T (1996) Modeling of acne in vitro. J Invest Dermatol 106:176–182
Imperato-McGinley J, Gautier T, Cai LQ et al (1993) The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 76:524–528
Ingham E, Eady EA, Goodwin CE et al (1992) Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98:895–901
Jahns AC, Lundskog B, Ganceviciene R et al (2012) An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case control study. Br J Dermatol 167:50–58
Kurokawa I, Danby FW, Ju Q et al (2009) New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 18:821–832
Letawe C, Boone M, Pierard GE (1998) Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 23:56–58
Marynick SP, Chakmajian ZH, McCaffree DL, Herdon JH (1983) Androgen excess in cystic acne. N Engl J Med 308:981–986
Melnik BC (2012) Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol 4:20–32
Nakatsuji T, Kao MC, Zhang L et al (2010) Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating β-defensin-2 expression. J Invest Dermatol 130:985–994
Nast A, Bayerl C, Borelli C et al (2010) S2k-Leitlinie zur Therapie der Akne. J Dtsch Dermatol Ges 8(Suppl 2):1–59 [Erratum and Adendum: J Dtsch Dermatol Ges 8(Suppl 2):e1–e4]
Schäfer T, Nienhaus A, Vieluf D et al (2001) Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 145:100–104
Trivedi NR, Cong Z, Nelson AM et al (2006) Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 126:2002–2009
Witchel SF, Recabarren SE, Gonzalez F et al (2012) Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine 42:526–534
Xu Y, Yang L, Yang T et al (2008) Expression pattern of cyclooxygenase-2 in normal rat epidermis and pilosebaceous unit during hair cycle. Acta Histochem Cytochem 41:157–163
Zouboulis CC (2001) Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277–279
Zouboulis CC (2004) Acne: sebaceous gland action. Clin Dermatol 22:360–366
Zouboulis CC (2008) The sebaceous gland in adolescent age. Eur J Pediatr Dermatol 18:150–154
Zouboulis CC (2009) Acne vulgaris and rosacea. In: Granstein RD, Luger T (Hrsg) Neuroimmunology of the skin – basic science to clinical practice. Springer, Berlin, S 219–232
Zouboulis CC (2009) Propionibacterium acnes and sebaceous lipogenesis: a love-hate relationship? J Invest Dermatol 129:2093–2096
Zouboulis CC (2009) Zileuton, a new efficient and safe systemic anti-acne drug. Dermatoendocrinol 1:188–192
Zouboulis CC (2010) Acne vulgaris – Rolle der Hormone. Hautarzt 61:107–114
Zouboulis CC (2010) Moderne Aspekte der Aknepathogenese. J Dtsch Dermatol Ges 8(Suppl 1):7–14
Zouboulis CC, Eady A, Philpott M et al (2005) What is the pathogenesis of acne? Exp Dermatol 14:143–152
Zouboulis CC, Rabe T (2010) Hormonelle Antiandrogene in der Aknetherapie. J Dtsch Dermatol Ges 8(Suppl 1):60–74
Zouboulis CC (2006) Moderne Aspekte der Aknepathogenese. Akt Dermatol 32:296–302
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
__ ____
Der Beitrag entspricht einer aktualisierten Version der Veröffentlichung: Zouboulis CC (2010) Moderne Aspekte der Aknepathogenese. J Dtsch Dermatol Ges 8(Suppl 1):S7–S14.
Rights and permissions
About this article
Cite this article
Zouboulis, C. Pathophysiologie der Akne. Hautarzt 64, 235–240 (2013). https://doi.org/10.1007/s00105-012-2457-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-012-2457-1